Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Impact of Low Calorie and Low Nitrogen Parenteral Nutrition Support on the Clinical Outcome of Postoperative Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00247338
Recruitment Status : Completed
First Posted : November 1, 2005
Last Update Posted : May 12, 2008
Sponsor:
Collaborators:
Guangzhou S Y S Medical School hospital
Wuhan TongJi Hospital
Beijing 301 hospital
Jie-Ping Wu Medical Foundation
Information provided by:
Sino-Swed Pharmaceutical Corporation

Brief Summary:
The study is designed to investigate the influence of parenteral nutrition (PN) with low nitrogen and calorie supply on the clinical outcome of patients after an operation compared to that of traditional PNs.

Condition or disease Intervention/treatment Phase
Gastrointestinal Neoplasms Postoperative Complications Drug: low calorie, low nitrogen parenteral nutrition for patient with NRS score 3 Phase 4

Detailed Description:

Wretlind from Sweden invented fat emulsion as early as 1961, which has been applied to parenteral nutrition. Dudrick and Wilmore from America introduced intravenous nutrition containing carbohydrates and amino acids, which was termed as high intravenous nutrition in 1967. Afterwards, it was proven that this treatment cannot improve clinical outcome but increases complications, such as infection, etc. Because of the action of catecholamine and corticosteroids under stress after an operation, insulin resistance becomes a main indicator of endocrine problems for patients. Under such circumstances, even intake of glucose at physiological doses can result in hyperglycosemia and increase the incidence of complications of infection and metabolism. Overseas and domestic scholars studied parenteral nutrition (PN) with low nitrogen and calorie supply long ago, and the results revealed that PN with low nitrogen and calorie supply can significantly decrease oxygen consumption of patients under stress of an operation, alleviate the inflammation response, reduce the rate of cholestasis and cut the treatment cost during hospitalization. On the other hand, catabolism of protein significantly increases after operation and trauma, but it cannot be simply corrected by high dose amino acid intake. Contrarily, improperly increasing of the intake of amino acids aggravates metabolism further. A domestic study on PN with a low calorie supply has revealed benefits on the clinical outcome of patients after an operation, such as a domestic randomised controlled study that has proven that intravenous nutrition with a low nitrogen and calorie supply significantly lowered the level of blood glucose, cut nutrition related medicine costs, shortened the length of hospital stay and reduced the incidence of phlebitis after operation, and also has the tendency to reduce the incidence of complications after an operation. Meta analysis has revealed that PN with a low nitrogen and calorie supply can control blood glucose better and may reduce the incidence of infection related complications, and has the tendency of shortening the length of hospital stay.

The development of all-in-one PN has experienced the process of sequential single bottle infusion, poly-bottle serial infusion, hospital prepared all-in-one solution and industrialized three compartment bags, and currently, the utilization of industrialized three compartment bags has been the dominant tendency of clinical parenteral nutrition among countries in Europe and Asia. Domestically Kabiven peripheral (FK, Germany, 1440 ml H20040008, 1920 ml H20040019) are the first three compartment bags, which is a pre-filling standard all-in-one nutrition solution. The two specifications (1440 ml,1920 ml) first launched to the market already satisfy most demands of PN support for patients, and provide PN with a low nitrogen and calorie supplying administration platform for patients after operation, spare time for the preparation of all-in-one nutrition solution, and avoid preparing such solutions under the common clean condition in hospitals.

Up to now, there is no report of a randomized controlled study about the utilization of three compartment bags domestically.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 120 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Comparing With Traditional Nitrogen Calorie Parenteral Nutrition Support, the Impact of Low Calorie and Low Nitrogen Intake on the Clinical Outcome of Gastrointestinal Postoperative Patients, Multicentre Post-Marketing Clinical Study
Study Start Date : April 2005
Actual Primary Completion Date : April 2006
Actual Study Completion Date : May 2006

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Infectious complications [ Time Frame: POD+1 to POD+14 ]

Secondary Outcome Measures :
  1. Systemic inflammatory response syndrome [ Time Frame: POD+1 to POD + 7 ]
  2. The length of hospital stay after operation [ Time Frame: POD+1 to discharge ]
  3. Post-operative nutritional cost & total treatment cost [ Time Frame: POD+1 to discharge ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients undergone resection of stomach, intestine, or rectum, having the indication of nutrition
  • Nutrition risk screening scores around 3
  • The age of the patients must be between 18 to 80
  • The patients sign the confirmed consent letter
  • Weight falls in the range of either 45-56 kg or 60-75 kg

Exclusion Criteria:

  • Pregnant or breast feeding
  • Contraindication of fluid infusion, acute pulmonary edema, brain edema and functional insufficiency of the heart
  • Hypersensitive to the ingredient of the trial product nutrient
  • Chemotherapy within 7 days before the beginning of this trial
  • Unstable angina pectoris
  • Diabetes mellitus
  • Disorder of lipid metabolism: triglycerides, cholesterol increased by 1.5 times above the reference value
  • Abnormal renal function: serum creatinine or BUN 1.5 times above normal reference value
  • Abnormal liver function: ALT or serum total bilirubin 1.5 times above normal reference value
  • Having severe drug allergy history and/or asthma
  • On operation day, blood loss above 800 ml
  • Contraindication to parenteral nutrition
  • Receiving regular parenteral nutrition within 7 days before the trial

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00247338


Locations
Layout table for location information
China, Guangdong
Department of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China, 510080
China, Hubei
Department of General Surgery, Affiliated Hospital of Medical University of Tongji
Wuhan, Hubei, China, 430030
China
Department of General Surgery, General Hospital of PLA
Beijing, China, 100853
Sponsors and Collaborators
Sino-Swed Pharmaceutical Corporation
Guangzhou S Y S Medical School hospital
Wuhan TongJi Hospital
Beijing 301 hospital
Jie-Ping Wu Medical Foundation
Investigators
Layout table for investigator information
Principal Investigator: Wen-hua Zhan, MD,FACS First Affiliated Hospital, Sun Yat-Sen University
Study Chair: Zhu-Ming Jiang, MD, FACS Parenteral & Enteral Centre, Peking Union Medical College Hospital

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: ZM Jiang, Peking Union Medical Hospital
ClinicalTrials.gov Identifier: NCT00247338    
Other Study ID Numbers: Hypocaloric PN
First Posted: November 1, 2005    Key Record Dates
Last Update Posted: May 12, 2008
Last Verified: May 2008
Keywords provided by Sino-Swed Pharmaceutical Corporation:
parenteral nutrition
low calorie
low nitrogen
gastrointestinal neoplasms
gastrointestinal diseases
gastrectomy
colectomy
rectectomy
operations
Additional relevant MeSH terms:
Layout table for MeSH terms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Postoperative Complications
Neoplasms
Pathologic Processes
Neoplasms by Site
Digestive System Diseases
Gastrointestinal Diseases